Perizam Oral Suspension (Clobazam)
Perizam (Clobazam) belongs to a group of medicines called ‘benzodiazepines’.
Perizam (Clobazam) is a 1,5-benzodiazepine indicated for:
adults for the short-term symptomatic treatment (2-4 weeks) only of anxiety that is severe, disabling or subjecting the individual to unacceptable distress.
In treatment of anxiety states associated with affective disorders, Perizam must only be used in conjunction with adequate treatments for the underlying disorder.
In patients with schizophrenic or other psychotic illnesses, use of benzodiazepines is recommended only for short term symptomatic management of hyperarousal and agitation. Benzodiazepines do not possess antipsychotic properties.
Perizam may be used as adjunctive therapy in epilepsy in adults or children over 2 years, if standard treatment with one or more anticonvulsants has failed: Treatment of simple or complex partial epilepsy with or without secondary generalisation and treatment of all types of generalised epilepsy (tonic/clonic, myoclonic, absence seizures).
Summary of Product Characteristics
Read this summary of product characteristics for further information about Clobazam Oral Suspension. Click below to navigate to the EMC.
Patient Information Leaflet
Read this patient information leaflet about Clobazam Oral Suspension, what it’s used for and possible side effects. Click below to navigate to the EMC
Perizam Oral Suspension (Clobazam)
| Click here for Audio Version | |
| Flavour | Raspberry |
| Storage Conditions | Do not store above 25°C. Do not refrigerate or freeze |
| Sucrose Free | |
| Shelf Life (Closed Bottle/Open Bottle) | 36 months / 28 days |
| PIP Code | 120-3439 |
| EAN Code | 5016119000126 |
| Sodium Levels | 2.3mg/ml |
| Ethanol Concentration | None |
Downloads
| Click here for Audio Version | |
| Flavour | Raspberry |
| Storage Conditions | Do not store above 25°C. Do not refrigerate or freeze |
| Sucrose Free | |
| Shelf Life (Closed Bottle/Open Bottle) | 36 months / 28 days |
| PIP Code | 120-3413 |
| EAN Code | 5016119000058 |
| Sodium Levels | 2.3mg/ml |
| Ethanol Concentration | None |
Downloads
Adverse Events
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk
Adverse events should also be reported to Rosemont at 0113 244 1400 or pharmacovigilance@rosemontpharma.com.
Contact us
For further product information and pricing please use the form below and a member of the team will be in touch
Stay updated via our App
A new Rosemont Pharmaceuticals App for Healthcare Professionals is launching soon.
Related Products
